US Whooping Cough Cases Surge
Analysis based on 6 articles · First reported Apr 24, 2025 · Last updated Apr 25, 2025
The rising whooping cough cases in the United States, as reported by the United States — Centers for Disease Control and Prevention, indicate a potential public health crisis that could strain healthcare systems and increase demand for related medical supplies and pharmaceuticals. The increasing anti-vaccine sentiment, highlighted by Dr. Ericka Hayes and Dr. Natasha Bagdasarian, could lead to further outbreaks of vaccine-preventable diseases, impacting public health spending and potentially affecting the stock performance of pharmaceutical companies involved in vaccine development and production.
The United States is experiencing a significant surge in whooping cough (pertussis) cases in 2025, with preliminary data from the United States — Centers for Disease Control and Prevention showing 8,485 cases, double the number from the previous year. This increase follows a trend from last year and is attributed to relaxed COVID-19 measures and a cyclical peak in the illness. Experts, including Dr. Ericka Hayes from the Children s Hospital of Philadelphia, point to increasing anti-vaccine sentiment and declining kindergarten vaccination rates, with vaccine exemptions at an all-time high, as contributing factors. The illness is particularly dangerous for infants, and the uptake of the vaccine among pregnant mothers is noted as insufficient. States like United States — Pennsylvania and United States — Michigan are heavily affected, with United States — Pennsylvania recording 207 cases and United States — Michigan 516 cases in 2025. Dr. Natasha Bagdasarian, United States — Michigan's chief medical executive, highlights varying vaccination rates in schools, creating vulnerable communities. Public health resources are also being stretched by concurrent measles outbreaks.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard